NO20000822D0 - Substituted 4-oxo-3-carboxamides as GABA Brain Receptor Ligands - Google Patents

Substituted 4-oxo-3-carboxamides as GABA Brain Receptor Ligands

Info

Publication number
NO20000822D0
NO20000822D0 NO20000822A NO20000822A NO20000822D0 NO 20000822 D0 NO20000822 D0 NO 20000822D0 NO 20000822 A NO20000822 A NO 20000822A NO 20000822 A NO20000822 A NO 20000822A NO 20000822 D0 NO20000822 D0 NO 20000822D0
Authority
NO
Norway
Prior art keywords
carboxamides
oxo
substituted
receptor ligands
brain receptor
Prior art date
Application number
NO20000822A
Other languages
Norwegian (no)
Other versions
NO20000822L (en
Inventor
Pamela Albaugh
Robert W Desimone
Gang Liu
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of NO20000822D0 publication Critical patent/NO20000822D0/en
Publication of NO20000822L publication Critical patent/NO20000822L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20000822A 1997-08-25 2000-02-18 Substituted 4-oxo-3-carboxamides as GABA Brain Receptor Ligands NO20000822L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25
PCT/US1998/017513 WO1999010347A1 (en) 1997-08-25 1998-08-24 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands

Publications (2)

Publication Number Publication Date
NO20000822D0 true NO20000822D0 (en) 2000-02-18
NO20000822L NO20000822L (en) 2000-04-13

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000822A NO20000822L (en) 1997-08-25 2000-02-18 Substituted 4-oxo-3-carboxamides as GABA Brain Receptor Ligands

Country Status (24)

Country Link
EP (1) EP1007526A1 (en)
JP (1) JP2001514181A (en)
KR (1) KR20010023313A (en)
CN (1) CN1268136A (en)
AP (1) AP2000001742A0 (en)
AU (1) AU753800B2 (en)
BG (1) BG104192A (en)
BR (1) BR9811362A (en)
CA (1) CA2301599C (en)
EG (1) EG21717A (en)
HU (1) HUP0003258A3 (en)
IL (1) IL134291A0 (en)
IS (1) IS5382A (en)
LV (1) LV12539B (en)
NO (1) NO20000822L (en)
NZ (1) NZ502548A (en)
OA (1) OA11293A (en)
PE (1) PE130999A1 (en)
PL (1) PL338783A1 (en)
SI (1) SI20270A (en)
SK (1) SK2162000A3 (en)
TW (1) TW574221B (en)
WO (1) WO1999010347A1 (en)
YU (1) YU10500A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371472A1 (en) * 1999-05-06 2000-11-16 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
WO2000071528A1 (en) * 1999-05-25 2000-11-30 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
SK4322003A3 (en) 2000-10-12 2003-09-11 Merck & Co Inc Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
DE60128936T2 (en) 2000-10-12 2008-04-10 Merck & Co, Inc. AZA AND POLYAZA NAPHTHALENYL ACID ACID AMIDE AS HIV INTEGRASE INHIBITORS
JP2004517860A (en) 2000-10-12 2004-06-17 メルク　エンド　カムパニー　インコーポレーテッド Aza- and polyaza-naphthalenylcarboxamides useful as HIV integrase inhibitors
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
HUP0303448A3 (en) * 2001-03-01 2005-05-30 Pfizer Prod Inc Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders
AR036256A1 (en) 2001-08-17 2004-08-25 Merck & Co Inc SODIUM SALT OF AN HIV INTEGRAS INHIBITOR, PROCESSES FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
AU2003216049B2 (en) 2002-01-17 2008-07-17 Merck Sharp & Dohme Corp. Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
ATE409187T1 (en) 2002-03-15 2008-10-15 Merck & Co Inc N-(SUBSTITUTED BENZYL)-8-HYDROXY-1,6-NAPHTHYRIDINE-7-CARBONIC ACID AMIDE AS HIV INTEGRASE INHIBITORS
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
WO2008046135A1 (en) * 2006-10-16 2008-04-24 Bionomics Limited Novel anxiolytic compounds
AU2007325836B2 (en) * 2006-11-22 2011-07-21 Clinical Research Associates, Llc Methods of treating mental retardation, Down's syndrome, fragile X syndrome and autism

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204162A1 (en) * 1972-05-08 1975-11-28 Yamanouchi Pharma Co Ltd PROCESS FOR THE PREPARATION OF AMPICILLIN DERIVATIVES
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD279887A1 (en) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun METHOD OF PREPARING D-ALPHA- (4 (1H) -1,5-NAPHTHYRIDONE-3-CARBOXAMIDO) -BENZYLPENICILLIN AND OTHER BETA LACTAMANTIBIOTICS
DD295360A5 (en) * 1987-07-03 1991-10-31 Akad Wissenschaften Process for the preparation of activated carboxylic acid esters
DD279875A1 (en) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun PROCESS FOR PREPARING ACTIVATED CARBONIC ACID ESTERS
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
IL134291A0 (en) 2001-04-30
SI20270A (en) 2000-12-31
AP2000001742A0 (en) 2000-02-24
BG104192A (en) 2001-05-31
EP1007526A1 (en) 2000-06-14
CA2301599C (en) 2003-03-25
TW574221B (en) 2004-02-01
CA2301599A1 (en) 1999-03-04
KR20010023313A (en) 2001-03-26
NO20000822L (en) 2000-04-13
WO1999010347A1 (en) 1999-03-04
AU9117398A (en) 1999-03-16
IS5382A (en) 2000-02-22
LV12539B (en) 2001-01-20
AU753800B2 (en) 2002-10-31
HUP0003258A2 (en) 2001-03-28
LV12539A (en) 2000-10-20
CN1268136A (en) 2000-09-27
PE130999A1 (en) 1999-12-16
HUP0003258A3 (en) 2001-05-28
OA11293A (en) 2002-11-19
SK2162000A3 (en) 2001-03-12
BR9811362A (en) 2000-08-22
JP2001514181A (en) 2001-09-11
YU10500A (en) 2002-10-18
PL338783A1 (en) 2000-11-20
NZ502548A (en) 2002-06-28
EG21717A (en) 2002-02-27

Similar Documents

Publication Publication Date Title
IS5354A (en) New compounds
IS5477A (en) compounds
ID22850A (en) PIRAZINA COMPOUNDS
NO994877D0 (en) Calcilitic compounds
NO20000822D0 (en) Substituted 4-oxo-3-carboxamides as GABA Brain Receptor Ligands
MX225999B (en) ANTIFUNGIC CRYSTAL POLYMORPH.
NO20003730D0 (en) Triazolo-pyridazine derivatives as ligands for GABA receptors
DK0975623T3 (en) Indazolamide compounds as sertoninergic agents
AU2217200A (en) 2-amino-9-alkylpurines: gaba brain receptor ligands
NO20000953L (en) Compounds that possess neuronal activity
EE9900448A (en) Compounds
DE69834219D1 (en) demultiplexer
IS5237A (en) compounds
IT236150Y1 (en) ACCESSORY FOR CYCLES
NO996544D0 (en) compounds
DK0915076T3 (en) Process for the preparation of trans- (R, R) -actinol
NO995007D0 (en) compounds
ID24348A (en) METHODS FOR MELAMIN PREPARATION
DE59808274D1 (en) BRAIN PATEL
AU2653499A (en) Oxo-dipyridoimidazole-carboxamides: gaba brain receptor ligands
DE29702249U1 (en) Brain spatula
SE9702775D0 (en) Novel compounds
ZA987957B (en) Substituted 4-oxo-napthyridine-3-carboxamides: gaba brain receptor ligands.
LV11827A (en) Strainer for Celamcras
IT1297612B1 (en) HARNESS FOR CYCLISTS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application